Clinical trials · source year

2026 clinical trial records, page 3

612 selected, source-linked clinical trial records dated 2026. This is selective source coverage, not a complete timeline.

Dated records

612 selected records.

Peptide profiles

74 connected profiles.

Cited sources

612 distinct public records.

Cited chronology

Dated source records

All record types in 2026 →

June 2026

33 records on this page

Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT06326190

PeptideScanner retained ClinicalTrials.gov record NCT06326190 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Maridebart cafraglutide

ClinicalTrials.gov record NCT07226765

PeptideScanner retained ClinicalTrials.gov record NCT07226765 at 2026-07-30T16:19:03.046Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Maridebart cafraglutide

ClinicalTrials.gov record NCT07225686

PeptideScanner retained ClinicalTrials.gov record NCT07225686 at 2026-07-30T16:19:03.064Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04529044

PeptideScanner retained ClinicalTrials.gov record NCT04529044 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04954820

PeptideScanner retained ClinicalTrials.gov record NCT04954820 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

May 2026

42 records on this page

April 2026

44 records on this page

March 2026

46 records on this page

Gallium Ga 68 dotatate

ClinicalTrials.gov record NCT04040088

PeptideScanner retained ClinicalTrials.gov record NCT04040088 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.

Source: ClinicalTrials.gov ↗

→

Gallium Ga 68 dotatate

ClinicalTrials.gov record NCT04069299

PeptideScanner retained ClinicalTrials.gov record NCT04069299 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.

Source: ClinicalTrials.gov ↗

→

Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04261855

PeptideScanner retained ClinicalTrials.gov record NCT04261855 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

February 2026

22 records on this page

Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04711135

PeptideScanner retained ClinicalTrials.gov record NCT04711135 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-02-12, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

January 2026

13 records on this page

Maridebart cafraglutide

ClinicalTrials.gov record NCT07229157

PeptideScanner retained ClinicalTrials.gov record NCT07229157 at 2026-07-30T16:25:18.016Z. Its registry update date was 2026-01-23, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT03972488

PeptideScanner retained ClinicalTrials.gov record NCT03972488 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-01-21, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→